Cited by 26Alzheimer's disease research and treatmentsMolecular Sensors and Ion DetectionLuminescence and Fluorescent Materials

The chelation targeting metal–Aβ40 aggregates may lead to formation of Aβ40 oligomers

Zhang, Yong, Chen, Li-Yuan, Yin, Wen-Xing, Yin, Jun, Zhang, Shi-Bing, Liu, Chang-Lin·2011·Dalton Transactions

Abstract

The fluorescent chelator (FC-1) was designed by combining a metal-chelating unit and a ThT-based Aβ aggregate-binding fluorescent unit. FC-1 is a cell membrane-penetrable chelator with a moderate chelation ability to Cu(2+) and Zn(2+) and can target metal-Aβ40 aggregates. Treatment with FC-1 led to enhanced cytotoxicity of the aggregates, because the aggregates were converted into a pool of oligomers.

Integrity signals

Registry

Crossref · 10.1039/c1dt00020a

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two approaches have been pursued in BFC design: direct incorporation of metal-binding atom donors into the structural framework of an Aβ-interacting compound, and linking the metal-chelating and Aβ-binding molecular fragments.

    “In this context, two approaches have been pursued in BFC design. 31,49–58 One strategy is based on the direct incorporation of metal-binding atom donors into the structural framework of an Aβ-interacting compoud (Scheme 1, approach A), and the other involves linking the metal-chelating and Aβ-binding molecular fragments (Scheme 1, approach B).”
  • Other reported BFCs have employed benzothiazole fragments as amyloid-binding motifs, but no binding affinities for the Aβ species have been measured for those systems.

    “While other reported BFCs have employed benzothiazole fragments as amyloid-binding motifs, no binding affinities for the Aβ species have been measured for those systems.49,53,54”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, Y., Chen, L.-Y., Yin, W.-X., Yin, J., Zhang, S.-B., & Liu, C.-L.
Affiliations
Central China Normal University (CN)
Venue
Dalton Transactions
Published
2011
Volume
40
Issue
18
Pages
4830
ISSN
  • 1477-9226 (ISSN-L)
  • 1477-9234
OpenAlex
W2144307327
Cited by
26
References
25
Citations by year
2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 2 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 5
FWCI
1.74
Type
journal article
Language
en
Open access
closed
Locations
  • Dalton Transactions (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Physical Sciences › Materials Science › Materials Chemistry › Luminescence and Fluorescent Materials
Keywords
Aβ40, copper(II) chelation, amyloid aggregates, oligomerization, cytotoxicity, Alzheimer's disease
MeSH terms
Chelating Agents, Copper, HeLa Cells, Humans, Hydrogen-Ion Concentration, Metals, Molecular Conformation, Peptide Fragments, Zinc, Amyloid beta-Peptides, Coordination Complexes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review